Interferon Beta-1b injection bulk supplier for pharma manufacturers

Interferon Beta-1b Injection 250 mcg Suppliers & Bulk Manufacturers

Available Forms: Injectable Solution

Available Strengths: 250 mcg

Reference Brands: Betaseron, Extavia(US)

Interferon beta-1b 250 micrograms powder and diluent for subcutaneous injection, used every other day in relapsing multiple sclerosis. For hospital neurology pharmacies, tender buyers and licensed importers.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Interferon Beta-1b Injection? List it or send an offer →

Product Description:

Interferon beta-1b is a recombinant form of human interferon beta made in E. coli. It is not glycosylated and has a serine in place of cysteine at position 17, which sets it apart from interferon beta-1a. In multiple sclerosis it dampens immune activity by reducing pro-inflammatory cytokines and limiting the entry of immune cells into the central nervous system. The 250 microgram dose comes as a freeze-dried powder with a prefilled diluent syringe, reconstituted to 1 mL for subcutaneous injection every other day.

It is used in relapsing-remitting multiple sclerosis, in secondary progressive disease with continuing relapses, and after a first demyelinating event suggestive of the disease. Treatment usually starts at a quarter dose and is increased over a few weeks to improve tolerance. Flu-like symptoms after injection are common and ease with time and simple analgesics. Injection-site reactions, including occasional necrosis, call for site rotation and good technique. Liver tests and blood counts are checked regularly, and depression, thrombotic microangiopathy and nephrotic syndrome are labelled risks.

Sourcing notes. The reference product is stored at room temperature, not above 25°C and not frozen, so it can travel without a refrigerated cold chain, though temperature should still be logged. Titration packs exist for the first weeks, so state whether you need starter or standard packs. Ask for the batch CoA, batch release certificate, GMP certificate and CoPP. Some regulators require national lot release for biologics. It is prescription-only, used by neurologists. For tenders, say whether autoinjectors or patient training material are expected.

Interferon Beta-1b Injection — third party manufacturing & bulk supply

Interferon Beta-1b Injection 250 mcg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Interferon Beta-1b Injection is supplied as Injectable Solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Interferon Beta-1b Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Interferon Beta-1b Injection →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Interferon beta-1b is used for the management of relapsing forms of multiple sclerosis (MS). It helps reduce the frequency of relapses and may slow the progression of physical disability associated with the disease. It works by modulating the immune system and reducing inflammatory processes that damage nerve cells in the central nervous system.

Interferon beta-1b is a recombinant protein produced using biotechnology methods. It is created through genetic engineering using modified bacterial cells that produce a form of the human interferon beta protein, which plays a role in regulating immune responses.

Common trade names of Interferon beta-1b include Betaseron and Extavia.

Interferon beta-1b products are manufactured by companies such as Bayer and Novartis, depending on the brand and market.

The generic name is Interferon beta-1b.

Well-known brand names include Betaseron and Extavia.

Interferon beta-1b is manufactured in regulated pharmaceutical facilities in countries such as the United States and European countries under strict biopharmaceutical manufacturing and quality standards.